DoloRadix AB is a pain management company with a clinical focus, with the desire and curiosity to cure pain for patients all over the world.

Our misson is to radically change the daily management of musculoskeletal pain across all patient groups.

We engage with leading universities to develop new clinical concepts, including diagnostic tools, artificial intelligence and tools for decision support and treatments, that will profoundly change the recovery rate for patients with musculoskeletal pain, including a remarkable shortening of the treatment time, increase the quality of life for the individual patient, and lower the health care costs related to pain disorders. 

DoloRadix AB was established 2016 with the purpose to be the vehicle to acquire and further develop all the IPR, competence and expertise that have been developed by Mårten Prosell in his clinical work for Progress Ortopedisk Medicin AB, specialized in musculoskeletal related pain.